Page 28 - Read Online
P. 28

Page 4 of 14                    Xu et al. Cancer Drug Resist 2024;7:13  https://dx.doi.org/10.20517/cdr.2023.141













































                Figure 1. Biosynthetic mechanisms for circRNAs. (A) Lariat-driven circularization: lariat causes exons or introns that were originally far
                apart to come closer; (B) Intron pairing-driven circularization: complementary sequences in introns promote circRNA circularization by
                base pairing to bring the 3' splice acceptor site and the 5' splice donor site closer together in spatial conformation; (C) RBP-dependent
                circularization: RBPs bind to intronic sequences or specific motifs within flanking introns near the splice site and indirectly bridge the
                distance between upstream and downstream exons. RBP: RNA binding protein.

               enhanced the expression of glycosylation hydrolase O-GlcNAcase (OGA) through miR-503-5p to regulate
               lipid  metabolism  and  thus  promote  TNBC  development . Similarly,  CircWHS  promotes  TNBC
                                                                    [37]
               progression by regulating AKT3 expression through miR-212-5p to enhance glycolytic capacity . In terms
                                                                                                [38]
               of drug resistance, it was found that CircEGFR regulates expression of the epidermal growth factor receptor
               (EGFR) through miR-1299, which in turn promotes TNBC progression and resistance to trastuzumab and
               pertuzumab in combination with taxanes (THP) therapy . In addition, CircDUSP1 enhances expression of
                                                               [39]
               the disheveled binding antagonist of beta-catenin 2 (DACT2) via miR-761, thereby promoting TNBC
                                   [40]
               sensitivity to paclitaxel ; circUBE2D2 silences miR-512-3p to enhance CDCA3 to promote doxorubicin
               resistance in TNBC ; and CircNCOR1 mediates TNBC radiotherapy resistance via hsa-miR-638 . At the
                                                                                                  [42]
                                [41]
               immune microenvironment level, circFGFR4 promotes TNBC immune evasion and resistance to PD-1
               immunotherapy through miR-185-5p . A number of circRNA-miRNA networks were summarized in
                                                [43]
               Table 1.
               Binding to proteins
               Results from a cross-linked immunoprecipitation experiment showed that circRNA interacts with various
               proteins . The first study to demonstrate the function of protein binding was conducted on the splicing
                      [68]
               factor protein gene encoding muscle blindness (MBL) in Drosophila melanogaster, a homolog of human
   23   24   25   26   27   28   29   30   31   32   33